29, July 2026

Individualized Homoeopathic Treatment in Chronic Childhood Palmoplantar Psoriasis: A CARE-Compliant Case Report

VOLUME-12; ISSUE-7; JULY-2026

Author(s): Dr. Susanna Alajangi

Authors Affiliations:

Assistant Professor, Department of Physiology and Biochemistry, MNR Homoeopathic Medical College and Hospital, Sangareddy, India & Consultant Physician – Adonai Rofecha Homeopathic Clinic, Vinukonda, Andhra Pradesh, India.

DOIs:10.2015/IJIRMF/202607015     |     Paper ID: IJIRMF202607015


Abstract
Keywords
Cite this Article/Paper as
References

Abstract

Background: Psoriasis is a chronic, immune-mediated inflammatory skin disease marked by epidermal hyperproliferation and dysregulated innate and adaptive immunity. Roughly one in three cases begins in childhood or adolescence, when the physical discomfort is often compounded by psychosocial distress and a measurable drop in quality of life. Palmoplantar involvement is among the more disabling presentations: fissuring, hyperkeratosis, pain, and unrelenting itch make ordinary tasks difficult. Corticosteroids and other conventional agents can control the disease while they are used, but relapse after withdrawal is common, and long-term safety in children remains a concern. Individualized homoeopathy instead selects a remedy from the totality of a patient's physical and psychological presentation. We report the course of a child with longstanding palmoplantar psoriasis treated on this basis.

Case Presentation: A 13-year-old girl presented with a four-year history of intense itching, burning, hyperkeratosis, painful fissuring, and silvery scaling affecting both palms and soles, as well as the knees and elbows. Topical corticosteroids and antihistamines had given only temporary relief, with symptoms recurring soon after each course ended. Case-taking uncovered a significant psychological trauma in early childhood together with persistent emotional suppression, fearfulness, and social withdrawal, alongside the characteristic skin findings. On the totality of this picture, a single dose of Natrum muriaticum 200C was prescribed, with placebo given at subsequent follow-up visits.

Outcome: Over the following eight months the itching and burning subsided, the fissures healed, scaling disappeared, and skin texture normalized, culminating in complete clinical remission. At extended follow-up roughly eighteen months later, the patient remained free of recurrence.

Conclusion: A single case cannot establish efficacy or causality, but this report adds to the descriptive literature on individualized homoeopathy in pediatric dermatological disease and points to the need for prospective observational studies and randomized trials in this area.

Keywords: childhood psoriasis; palmoplantar psoriasis; homoeopathy; Natrum muriaticum; individualized treatment; psychodermatology; case report; CARE guidelines

childhood psoriasis; palmoplantar psoriasis; homoeopathy; Natrum muriaticum; individualized treatment; psychodermatology; case report; CARE guidelines

Dr. Susanna Alajangi (2026); Individualized Homoeopathic Treatment in Chronic Childhood Palmoplantar Psoriasis: A CARE-Compliant Case Report, International Journal for Innovative Research in Multidisciplinary Field, ISSN(O): 2455-0620, Vol-12, Issue-7, Available on –   https://www.ijirmf.com/

REFERENCES:

  1. Orzan OA, Tutunaru CV, Ianosi SL. Understanding the intricate pathophysiology of psoriasis and related skin disorders. International Journal of Molecular Sciences. 2025 Jan 17;26(2):749.
  2. Na CH, Chung J, Simpson EL. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. 2019 Dec 2;6(12):133.
  3. Eichenfield LF, Paller AS, Tom WL, Sugarman J, Hebert AA, Friedlander SF, Siegfried E, Silverberg N, Cordoro KM. Pediatric psoriasis: evolving perspectives. Pediatric Dermatology. 2018 Mar;35(2):170-81.
  4. Sarac G, Koca TT, Baglan T. A brief summary of clinical types of psoriasis. Northern Clinics of Istanbul. 2016 Jun 14;3(1):79.
  5. Orzan OA, Tutunaru CV, Ianosi SL. Understanding the intricate pathophysiology of psoriasis and related skin disorders. International Journal of Molecular Sciences. 2025 Jan 17;26(2):749.
  6. Biazus Soares G, Mahmoud O, Yosipovitch G, Mochizuki H. The mind–skin connection: A narrative review exploring the link between inflammatory skin diseases and psychological stress. Journal of the European Academy of Dermatology and Venereology. 2024 May;38(5):821-34.
  7. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013;7:223. doi:10.1186/1752-1947-7-223.
  8. Bronckers IM, Paller AS, Van Geel MJ, Van de Kerkhof PC, Seyger MM. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Pediatric Drugs. 2015 Oct;17(5):373-84.
  9. Witt CM, Ludtke R, Baur R, Willich SN. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health. 2005;5:115. doi:10.1186/1471-2458-5-115.
  10. Itamura R. Effect of homeopathic treatment of 60 Japanese patients with chronic skin disease. Complementary Therapies in Medicine. 2007 Jun 1;15(2):115-20.
  11. Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H, Werthmann PG. CARE guidelines for case reports: explanation and elaboration document. Journal of Clinical Epidemiology. 2017 Sep 1;89:218-35.
  12. Rowe T. Homeopathic Methodology: Repertory, Case Taking, and Case Analysis. North Atlantic Books; 1998 Oct 27.
  13. Teut M, van Haselen RA, Rutten L, Lamba CD, Bleul G, Ulbrich-Zurni S. Case reporting in homeopathy — an overview of guidelines and scientific tools. Homeopathy. 2022 Feb;111(01):002-9.
  14. Koley M, Saha S, Das KD, Roy S, Goenka R, Chowdhury PR, Hait H, Bhattacharyya CK, Sadhukhan SK. Prospective evaluation of few homeopathic rubrics of Kent’s repertory from Bayesian perspective. Journal of Evidence-Based Complementary & Alternative Medicine. 2016 Oct;21(4):277-81.
  15. Naldi L. Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passe? Facts and controversies. Clinics in Dermatology. 2010 Jan 1;28(1):67-72.
  16. Naldi L. Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passe? Facts and controversies. Clinics in Dermatology. 2010 Jan 1;28(1):67-72.
  17. Robinson A, Kardos M, Kimball AB. Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 2012 Mar 1;66(3):369-75.
  18. Finlay AY, Khan G. Dermatology Life Quality Index (DLQI) — a simple practical measure for routine clinical use. Clinical and Experimental Dermatology. 1994 May;19(3):210-6.
  19. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021 Apr 3;397(10281):1301-1315. doi:10.1016/S0140-6736(20)32549-6. PMID: 33812489.
  20. Evers AW, Verhoeven EW, Kraaimaat FW, De Jong EM, De Brouwer SJ, Schalkwijk J, Sweep FC, Van De Kerkhof PC. How stress gets under the skin: cortisol and stress reactivity in psoriasis. British Journal of Dermatology. 2010 Nov 1;163(5):986-91.
  21. Chikramane PS, Suresh AK, Kane SG, Bellare JR. Metal nanoparticle induced hormetic activation: a novel mechanism of homeopathic medicines. Homeopathy. 2017 Aug;106(3):135-144. doi:10.1016/j.homp.2017.06.002. Epub 2017 Jul 21. PMID: 28844286.
Post Views: 29

Download Full Paper

Download PDF No. of Downloads:5 | No. of Views: 22